Current Cancer Drug Targets
Title:Meet Our Editorial Board Member
Volume: 18 Issue: 2
Author(s): J.L.-S. Au
Affiliation:
Export Options
About this article
Cite this article as:
Au J.L.-S. , Meet Our Editorial Board Member, Current Cancer Drug Targets 2018; 18 (2) . https://dx.doi.org/10.2174/156800961802180115100706
DOI https://dx.doi.org/10.2174/156800961802180115100706 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
31
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting BMP9-Promoted Human Osteosarcoma Growth by Inactivation of Notch Signaling
Current Cancer Drug Targets The Functions of Heparanase in Human Diseases
Mini-Reviews in Medicinal Chemistry Wnt Signaling and Prostate Cancer
Current Drug Targets The Heat Shock Protein 90 Chaperone Complex: An Evolving Therapeutic Target
Current Cancer Drug Targets Retraction Note: Low Doses of CPS49 and Flavopiridol Combination as Potential Treatment for Advanced Prostate Cancer
Current Pharmaceutical Biotechnology Antiangiogenic Therapy and Ovarian Cancer
Current Women`s Health Reviews Synthesis of 2-Substituted 4-Arylidene-5(4H)-oxazolones as Potential Cytotoxic Agents in the Presence of Lemon Juice as a Biocatalyst
Combinatorial Chemistry & High Throughput Screening Biomarkers of Oxidative Stress and the Relationship to Cigarette Smoking
Mini-Reviews in Organic Chemistry Jade-1: its structure, regulation and functions in the renal cancer.
Current Molecular Medicine Patent Ductus Arteriosus in the Preterm Infant: An Update on Morbidity and Mortality
Current Pediatric Reviews Editorial [Hot Topic: Pharmaceutical Reactivation of p53 Pathways in Cancer (Executive Guest Editor: Asfar S. Azmi)]
Current Pharmaceutical Design PTPN13/PTPL1: An Important Regulator of Tumor Aggressiveness
Anti-Cancer Agents in Medicinal Chemistry Recent Progresses in Organic-Inorganic Nano Technological Platforms for Cancer Therapeutics
Current Medicinal Chemistry Recent Developments of Targeted Therapies in the Treatment of Non-Small Cell Lung Cancer
Current Drug Discovery Technologies The Evaluation of Multivariate Adaptive Regression Splines for the Prediction of Antitumor Activity of Acridinone Derivatives
Medicinal Chemistry “Bridge Proteins” Link Inflammation and Metabolic Diseases: Potential Targets for Therapeutics
Current Protein & Peptide Science Lymphangiogenesis and Anti-Tumor Immune Responses
Current Molecular Medicine <i>In Silico</i> Designing a Novel Multi-epitope DNA Vaccine against Anti-apoptotic Proteins in Tumor Cells
Current Proteomics Exploring the Unexplored Practical and Alternative Synthesis of 3- (Trifluoromethyl)-Triazolopiperazine the Key Intermediate for Sitagliptin
Letters in Organic Chemistry Monoclonal Antibodies Production Against a 40KDa Band of Hydatid Cyst Fluid
Recent Patents on Biotechnology